Back to Search

Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance


  • Protocol Number: 201606003
  • Principal Investigator: Jacoby, Meagan
  • Cancer Types: Leukemia, Myeloma, and Hematologic

For more information on this trial, contact us here:

Phone
800-600-3606
Email
info@ccadmin.wustl.edu

Brief Summary

Protocol Interventions